KLK Capital Management’s Merck MRK Stock Holding History

KLK Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,221	Closed	-$328K	–	61
2021 Q2	$328K	Buy	+4,221	New	+$314K	0.28%	47

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

KLK Capital Management's MRK Position: Q3 2021 in Review

KLK Capital Management sold out of Merck (MRK) in Q3 2021, closing a stake of 4,221 shares — an estimated $328K sold.

KLK Capital Management first reported a position in MRK in Q2 2021 and held it in 1 quarter. The position peaked at $328K in Q2 2021. 2,648 funds tracked by Wall St. Rank hold MRK as of Q3 2021.

KLK Capital Management reported no remaining Merck position as of Q3 2021 after selling out during the quarter.
KLK Capital Management sold 4,221 Merck shares in Q3 2021, an estimated $328K.
KLK Capital Management first reported a position in Merck in Q2 2021 and held it in 1 quarter.
KLK Capital Management's Merck position peaked at $328K in Q2 2021.
2,648 funds tracked by Wall St. Rank held Merck as of Q3 2021.

Based on KLK Capital Management's 13F filing for Q3 2021, filed 9 Nov 2021.